Analyst Ratings For NASDAQ:KOOL – Cesca Therapeutics (NASDAQ:KOOL)
Today, HC Wainwright initiated coverage on NASDAQ:KOOL – Cesca Therapeutics (NASDAQ:KOOL) with a Buy with a price target of $0.54 ➝ $1.50.
Some recent analyst ratings include
- 5/23/2018-HC Wainwright initiated coverage with a Buy rating.
- 5/12/2017-Maxim Group Reiterated Rating of Hold.
Recent Insider Trading Activity For NASDAQ:KOOL – Cesca Therapeutics (NASDAQ:KOOL)
NASDAQ:KOOL – Cesca Therapeutics (NASDAQ:KOOL) has insider ownership of 3.90% and institutional ownership of 2.41%.
- On 12/26/2016 (Hong Kong) Ltd Boyalife, Major Shareholder, bought 6,102,942 with an average share price of $2.52 per share and the total transaction amounting to $15,379,413.84.
- On 11/10/2015 Kenneth Harris, Director, sold 80,858 with an average share price of $0.60 per share and the total transaction amounting to $48,514.80.
- On 11/9/2015 Kenneth Harris, Director, sold 48,468 with an average share price of $0.60 per share and the total transaction amounting to $29,080.80.
- On 11/6/2015 Kenneth Harris, Director, sold 30,190 with an average share price of $0.60 per share and the total transaction amounting to $18,114.00.
- On 11/3/2015 Kenneth Harris, Director, sold 10,510 with an average share price of $0.60 per share and the total transaction amounting to $6,306.00.
- On 11/2/2015 Kenneth Harris, Director, sold 5,700 with an average share price of $0.60 per share and the total transaction amounting to $3,420.00.
- On 10/29/2015 Kenneth Harris, Director, sold 8,632 with an average share price of $0.60 per share and the total transaction amounting to $5,179.20.
Recent Trading Activity for NASDAQ:KOOL – Cesca Therapeutics (NASDAQ:KOOL)
Shares of NASDAQ:KOOL – Cesca Therapeutics closed the previous trading session at 0.54 up +0.01 1.87% with 0.5120000243186951 shares trading hands.